<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>35(11)</volume><submitter>Miller CR</submitter><funding>NCI NIH HHS</funding><journal>Leukemia</journal><pagination>3287-3290</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8490482</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients.</pubmed_title><pmcid>PMC8490482</pmcid><funding_grant_id>P30 CA016058</funding_grant_id><funding_grant_id>R01 CA240493</funding_grant_id><pubmed_authors>Maddocks KJ</pubmed_authors><pubmed_authors>Miller CR</pubmed_authors><pubmed_authors>Lapalombella R</pubmed_authors><pubmed_authors>Jaglowski SM</pubmed_authors><pubmed_authors>Bhat S</pubmed_authors><pubmed_authors>Hertlein EK</pubmed_authors><pubmed_authors>Labanowska J</pubmed_authors><pubmed_authors>Woyach JA</pubmed_authors><pubmed_authors>Heerema NA</pubmed_authors><pubmed_authors>Abruzzo LV</pubmed_authors><pubmed_authors>Ruppert AS</pubmed_authors><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Grever M</pubmed_authors><pubmed_authors>Kittai AS</pubmed_authors><pubmed_authors>Byrd JC</pubmed_authors><pubmed_authors>Rogers KA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients.</name><description/><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2025-04-04T22:33:47.893Z</modification><creation>2025-02-19T03:24:05.618Z</creation></dates><accession>S-EPMC8490482</accession><cross_references><pubmed>33820961</pubmed><doi>10.1038/s41375-021-01237-x</doi></cross_references></HashMap>